Claudin-1 re-expression as a therapeutic strategy in Triple-negative breast cancer: transcriptional regulation.
- DOI
- 10.1007/s11033-026-13111-z
- Published
- 2026 Nov 6
- Container
- Molecular biology reports
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11033-026-13111-z,
title = {Claudin-1 re-expression as a therapeutic strategy in Triple-negative breast cancer: transcriptional regulation.},
author = {Kuntz S and Geoffroy-Guiraud M and Abdoun L and Felpin J and Boisbrun M and Bouzinba-Ségard H and Faure C and Grillier-Vuissoz I},
year = {2026},
journal = {Molecular biology reports},
doi = {10.1007/s11033-026-13111-z},
url = {https://doi.org/10.1007/s11033-026-13111-z}
}RIS
TY - JOUR TI - Claudin-1 re-expression as a therapeutic strategy in Triple-negative breast cancer: transcriptional regulation. AU - Kuntz S AU - Geoffroy-Guiraud M AU - Abdoun L AU - Felpin J AU - Boisbrun M AU - Bouzinba-Ségard H AU - Faure C AU - Grillier-Vuissoz I PY - 2026 JO - Molecular biology reports DO - 10.1007/s11033-026-13111-z UR - https://doi.org/10.1007/s11033-026-13111-z ER -
APA
S, K., M, G., L, A., J, F., M, B., H, B., C, F., & I, G. (2026). Claudin-1 re-expression as a therapeutic strategy in Triple-negative breast cancer: transcriptional regulation.. Molecular biology reports. https://doi.org/10.1007/s11033-026-13111-z
Source records
- pubmed · retrieved 2026-11-10T14:07:13.531Z